Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision tag, v3.6.6, was added and the previous tag, v3.6.5, was removed. This reflects an update to the site's release information rather than content changes on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows a generic error page instead of the study record details. This indicates the resource is currently unavailable.SummaryDifference21%

- Check46 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a back-end or content-management update. This update does not modify the trial details or other substantive content displayed on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 to reflect a new page version.SummaryDifference0.0%

- Check74 days agoChange DetectedThe revision tag was updated: 'Revision: v3.6.2' was added and the previous 'Revision: v3.6.0' tag was removed.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded user guidance sections and a recruitment-status notice to improve navigation and participation clarity. Updated formatting of the Intervention/Treatment heading and bumped the site revision from v3.5.5 to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.